View in EDS

Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines.

Saved in:
Bibliographic Details
Title: Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines.
Authors: Belouin SJ; United States Public Health Service, Germantown, MD, USA; Substance Abuse and Mental Health Services Administration (SAMHSA), Rockville, MD, USA; Pain and Palliative Care, NIH Clinical Research Center, Bethesda, MD, USA. Electronic address: sjbelouin@gmail.com., Averill LA; Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX, USA; US Department of Veterans Affairs, Michael E. DeBakey Veterans Administration Medical Center, Houston, TX, USA; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA; US Department of Veterans Affairs, National Center for PTSD - Clinical Neurosciences Division, Orange, CT, USA; Reason for Hope, New York, NY, USA., Henningfield JE; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Research, Health Policy and Abuse Liability, Pinney Associates, Bethesda, MD, USA., Xenakis SN; Reason for Hope, New York, NY, USA; United States Army, Hallandale Beach, FL, USA; Uniformed Services University of the Health Sciences (UHSUS), Bethesda, MD, USA., Donato I; Office of Prevention Innovation, Center for Substance Abuse Prevention, SAMHSA, Rockville, MD, USA., Grob CS; David Geffen School of Medicine at University of California (UCLA), Los Angeles, CA, USA; Division of Child and Adolescent Psychiatry, Harbor-UCLA Medical Center, Torrance, CA, USA., Berger A; Pain and Palliative Care, NIH Clinical Research Center, Bethesda, MD, USA., Magar V; Gender, Equity and Human Rights, World Health Organization (WHO), Geneva, Switzerland., Danforth AL; The Lundquist Institute, Harbor-UCLA Medical Center, Torrance, CA, USA., Anderson BT; University of California San Francisco (UCSF) Department of Psychiatry & Behavioral Sciences, San Francisco, CA, USA; University of California Berkeley Center for the Science of Psychedelics, Berkeley, CA, USA.
Source: Neuropharmacology [Neuropharmacology] 2022 Nov 15; Vol. 219, pp. 109214. Date of Electronic Publication: 2022 Aug 13.
Publication Type: Journal Article; Review
Journal Info: Publisher: Pergamon Press Country of Publication: England NLM ID: 0236217 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7064 (Electronic) Linking ISSN: 00283908 NLM ISO Abbreviation: Neuropharmacology Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35973601
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Belouin+SJ%22">Belouin SJ</searchLink>; United States Public Health Service, Germantown, MD, USA; Substance Abuse and Mental Health Services Administration (SAMHSA), Rockville, MD, USA; Pain and Palliative Care, NIH Clinical Research Center, Bethesda, MD, USA. Electronic address: sjbelouin@gmail.com.<br /><searchLink fieldCode="AU" term="%22Averill+LA%22">Averill LA</searchLink>; Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX, USA; US Department of Veterans Affairs, Michael E. DeBakey Veterans Administration Medical Center, Houston, TX, USA; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA; US Department of Veterans Affairs, National Center for PTSD - Clinical Neurosciences Division, Orange, CT, USA; Reason for Hope, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Henningfield+JE%22">Henningfield JE</searchLink>; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Research, Health Policy and Abuse Liability, Pinney Associates, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Xenakis+SN%22">Xenakis SN</searchLink>; Reason for Hope, New York, NY, USA; United States Army, Hallandale Beach, FL, USA; Uniformed Services University of the Health Sciences (UHSUS), Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Donato+I%22">Donato I</searchLink>; Office of Prevention Innovation, Center for Substance Abuse Prevention, SAMHSA, Rockville, MD, USA.<br /><searchLink fieldCode="AU" term="%22Grob+CS%22">Grob CS</searchLink>; David Geffen School of Medicine at University of California (UCLA), Los Angeles, CA, USA; Division of Child and Adolescent Psychiatry, Harbor-UCLA Medical Center, Torrance, CA, USA.<br /><searchLink fieldCode="AU" term="%22Berger+A%22">Berger A</searchLink>; Pain and Palliative Care, NIH Clinical Research Center, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Magar+V%22">Magar V</searchLink>; Gender, Equity and Human Rights, World Health Organization (WHO), Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Danforth+AL%22">Danforth AL</searchLink>; The Lundquist Institute, Harbor-UCLA Medical Center, Torrance, CA, USA.<br /><searchLink fieldCode="AU" term="%22Anderson+BT%22">Anderson BT</searchLink>; University of California San Francisco (UCSF) Department of Psychiatry & Behavioral Sciences, San Francisco, CA, USA; University of California Berkeley Center for the Science of Psychedelics, Berkeley, CA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220236217%22">Neuropharmacology</searchLink> [Neuropharmacology] 2022 Nov 15; Vol. 219, pp. 109214. <i>Date of Electronic Publication: </i>2022 Aug 13.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Pergamon+Press%22">Pergamon Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0236217 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-7064 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200283908%22">00283908 </searchLink><i>NLM ISO Abbreviation: </i>Neuropharmacology <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35973601
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.neuropharm.2022.109214
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 109214
    Titles:
      – TitleFull: Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Belouin SJ
      – PersonEntity:
          Name:
            NameFull: Averill LA
      – PersonEntity:
          Name:
            NameFull: Henningfield JE
      – PersonEntity:
          Name:
            NameFull: Xenakis SN
      – PersonEntity:
          Name:
            NameFull: Donato I
      – PersonEntity:
          Name:
            NameFull: Grob CS
      – PersonEntity:
          Name:
            NameFull: Berger A
      – PersonEntity:
          Name:
            NameFull: Magar V
      – PersonEntity:
          Name:
            NameFull: Danforth AL
      – PersonEntity:
          Name:
            NameFull: Anderson BT
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 11
              Text: 2022 Nov 15
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1873-7064
          Numbering:
            – Type: volume
              Value: 219
          Titles:
            – TitleFull: Neuropharmacology
              Type: main
ResultId 1